Hinokitiol Promotes Neural Repair After Spinal Cord Injury by Reprogramming Microglial Inflammatory and Redox Responses
Phytotherapy Research · 2026-11 · 40 (11) · 6564-6583
DOI: 10.1002/ptr.70447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 15.09.2026. Verfasst von Wenhao Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, Affiliated Nantong Clinical College of Nantong University, Nantong First People's Hospital, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Microglia, Monoterpenes, Tropolone. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Jiangsu Provincial, Nantong University Special Research Fund for Clinical Medicine.
Abstract (Originalsprache)
Secondary neuroinflammation and oxidative stress, driven partly by maladaptive microglial activation, limit recovery after spinal cord injury (SCI). We investigated whether hinokitiol promotes neural repair and whether nuclear factor erythroid 2‐related factor 2 (Nrf2) signaling mediates its effects. Male C57BL/6J mice received T10 contusive SCI and intraperitoneal vehicle or hinokitiol (20 mg/kg once daily for 7 days, starting 6 h after injury). Locomotor, electrophysiological, histological, and single‐nucleus transcriptomic outcomes were evaluated. In vitro, lipopolysaccharide‐challenged BV2 microglia, BV2–HT22 indirect cocultures, and pharmacological Nrf2 inhibition with ML385 were used to examine inflammatory, oxidative, and neuronal apoptosis outcomes. Hinokitiol improved locomotor and motor‐evoked potential outcomes; reduced lesion cavitation, collagen deposition, neuronal loss, demyelination, and astroglial activation; and shifted microglia from inflammatory/oxidative programs toward repair‐associated states. Hinokitiol reduced tumor necrosis factor‐α, interleukin‐1β, interleukin‐6, inducible nitric oxide synthase, cyclooxygenase‐2, and NADPH oxidases 2/4 in spinal cord tissue and BV2 cells. Hinokitiol‐pretreated microglia reduced HT22 apoptosis in coculture. Hinokitiol decreased Kelch‐like ECH‐associated protein 1 and increased Nrf2 and heme oxygenase‐1, whereas ML385 attenuated these effects and restored inflammatory and oxidative responses. Hinokitiol supports neural repair after SCI by reprogramming microglial inflammatory‐redox states, at least partly through Nrf2 signaling. These findings justify further pharmacokinetic, sex‐inclusive, and long‐term safety studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery, Affiliated Nantong Clinical College of Nantong University, Nantong First People's Hospital, Nantong, Jiangsu, China.
- Research Institute for Spine and Spinal Cord Disease of Nantong University, Nantong First People's Hospital, Nantong, Jiangsu, China.
ORCID-Profile: Qihao Fu, Chaochen Li, Chenxi Zhang, Zhiming Cui
Förderung
- Key Research and Development Program of Jiangsu Provincial
- Nantong University Special Research Fund for Clinical Medicine
Zitieren
APA
Zhang, W., Wang, J., Wang, T., Fu, Q., Xu, J., Li, C., Zhou, Z., Zhang, C., Xu, G., Xia, M., & Cui, Z. (2026). Hinokitiol Promotes Neural Repair After Spinal Cord Injury by Reprogramming Microglial Inflammatory and Redox Responses. Phytotherapy Research, 40(11), 6564-6583. https://doi.org/10.1002/ptr.70447
Vancouver
Zhang W, Wang J, Wang T, Fu Q, Xu J, Li C, et al. Hinokitiol Promotes Neural Repair After Spinal Cord Injury by Reprogramming Microglial Inflammatory and Redox Responses. Phytotherapy Research. 2026;40(11):6564-6583. doi:10.1002/ptr.70447
BibTeX
@article{Zhang2026,
author = {Zhang, Wenhao and Wang, Jing and Wang, Tianyi and Fu, Qihao and Xu, Jiawen and Li, Chaochen and Zhou, Zheng and Zhang, Chenxi and Xu, Guanhua and Xia, Mingjie and Cui, Zhiming},
title = {Hinokitiol Promotes Neural Repair After Spinal Cord Injury by Reprogramming Microglial Inflammatory and Redox Responses},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {11},
pages = {6564--6583},
doi = {10.1002/ptr.70447}
}
EUVIMED